BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 3 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,537,636 | -26.2% | 105,515 | -2.0% | 0.04% | -17.0% |
Q2 2023 | $3,439,244 | +4.2% | 107,712 | -0.1% | 0.05% | -14.5% |
Q1 2023 | $3,301,173 | -21.9% | 107,811 | -0.3% | 0.06% | -30.4% |
Q4 2022 | $4,228,417 | -25.6% | 108,116 | -9.3% | 0.08% | -20.2% |
Q3 2022 | $5,680,000 | +11.4% | 119,221 | -9.5% | 0.10% | +8.8% |
Q2 2022 | $5,101,000 | -43.5% | 131,777 | -16.4% | 0.09% | +9.6% |
Q1 2022 | $9,031,000 | -27.4% | 157,609 | +0.9% | 0.08% | +16.9% |
Q4 2021 | $12,442,000 | -5.6% | 156,131 | +3.0% | 0.07% | +4.4% |
Q3 2021 | $13,186,000 | -29.0% | 151,546 | +5.1% | 0.07% | -25.3% |
Q2 2021 | $18,562,000 | +61.2% | 144,219 | +0.2% | 0.09% | +46.8% |
Q1 2021 | $11,518,000 | +8.8% | 143,900 | +10.9% | 0.06% | +17.0% |
Q4 2020 | $10,590,000 | +304.8% | 129,711 | +22.1% | 0.05% | +231.2% |
Q3 2020 | $2,616,000 | +2.5% | 106,263 | +16.6% | 0.02% | -20.0% |
Q2 2020 | $2,551,000 | +57.8% | 91,105 | +1.4% | 0.02% | +5.3% |
Q1 2020 | $1,617,000 | – | 89,813 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |